Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

6262 ARTÍCULOS , VIENDO DEL 2611 AL 2625

Dysregulation of tyrosinase activity: a potential link between skin disorders and neurodegeneration

Jin W, Stehbens SJ, Barnard RT, Blaskovich MAT, Ziora ZM.

J Pharm Pharmacol. 2024 Jan 6;76(1):13-22. doi: 10.1093/jpp/rgad107.

Proteomic-Based Studies on Memory Formation in Normal and Neurodegenerative Disease-Affected Brains

da Silva Beraldo IJ, Prates Rodrigues M, Polanczyk RS, Verano-Braga T, Lopes-Aguiar C.

Adv Exp Med Biol. 2024;1443:129-158. doi: 10.1007/978-3-031-50624-6_7.

Interplay of mitochondria-associated membrane proteins and autophagy: Implications in neurodegeneration

Kulkarni PG, Mohire VM, Waghmare PP, Banerjee T.

Mitochondrion. 2024 May;76:101874. doi: 10.1016/j.mito.2024.101874. Epub 2024 Mar 20.

Neural circuit mechanisms of acupuncture effect: where are we now?

Wang X, Wang J, Han R, Yu C, Shen F.

Front Neurol. 2024 Jun 13;15:1399925. doi: 10.3389/fneur.2024.1399925. eCollection 2024.

Levodopa: From Biological Significance to Continuous Monitoring

Probst D, Batchu K, Younce JR, Sode K.

ACS Sens. 2024 Aug 23;9(8):3828-3839. doi: 10.1021/acssensors.4c00602. Epub 2024 Jul 24.

Effects and Mechanisms of Lutein on Aging and Age-Related Diseases

Ye J, Cheng J, Xiong R, Chen H, Huang S, Li H, Pang J, Zhang X, Zhu H.

Antioxidants (Basel). 2024 Sep 14;13(9):1114. doi: 10.3390/antiox13091114.

Approaches to Early Parkinson's Disease Subtyping

Hu M, Skjærbæk C, Borghammer P.

J Parkinsons Dis. 2024;14(s2):S297-S306. doi: 10.3233/JPD-230419.

α-Synuclein in Parkinson's Disease: 12 Years Later

Vekrellis K, Emmanouilidou E, Xilouri M, Stefanis L.

Cold Spring Harb Perspect Med. 2024 Nov 1;14(11):a041645. doi: 10.1101/cshperspect.a041645.

Management of Impulse Control and Related Disorders in Parkinson's Disease: An Expert Consensus

Debove I, Paschen S, Amstutz D, Cardoso F, Corvol JC, Fung VSC, Lang AE, Martinez Martin P, Rodríguez-Oroz MC, Weintraub D, Krack P, Deuschl G; and the Members of the ICBD in PD Management Consensus Group.

Mov Disord. 2024 Feb;39(2):235-248. doi: 10.1002/mds.29700. Epub 2024 Jan 17.

Ubiquitin Carboxyl-Terminal Hydrolase L1 and Its Role in Parkinson's Disease

Buneeva O, Medvedev A.

Int J Mol Sci. 2024 Jan 21;25(2):1303. doi: 10.3390/ijms25021303.

Targeting the adenosine A(2A) receptor for neuroprotection and cognitive improvement in traumatic brain injury and Parkinson's disease

Zhao Y, Zhou YG, Chen JF.

Chin J Traumatol. 2024 May;27(3):125-133. doi: 10.1016/j.cjtee.2023.08.003. Epub 2023 Aug 25.

Bilateral deep transcranial magnetic stimulation of motor and prefrontal cortices in Parkinson's disease: a comprehensive review

Hanlon CA, Lench DH, Pell G, Roth Y, Zangen A, Tendler A.

Front Hum Neurosci. 2024 Jan 24;17:1336027. doi: 10.3389/fnhum.2023.1336027. eCollection 2023.

The Molecular Impact of Glucosylceramidase Beta 1 (Gba1) in Parkinson's Disease: a New Genetic State of the Art

Dos Santos JCC, Mano GBC, da Cunha Barreto-Vianna AR, Garcia TFM, de Vasconcelos AV, Sá CSG, de Souza Santana SL, Farias AGP, Seimaru B, Lima MPP, Goes JVC, Gusmão CTP, Junior HLR.

Mol Neurobiol. 2024 Sep;61(9):6754-6770. doi: 10.1007/s12035-024-04008-8. Epub 2024 Feb 13.

Mitochondria-Associated MicroRNAs and Parkinson's Disease

Aaluri GR, Choudhary Y, Kumar S.

Neurosci Insights. 2024 May 24;19:26331055241254846. doi: 10.1177/26331055241254846. eCollection 2024.

A Comprehensive Approach to Parkinson's Disease: Addressing Its Molecular, Clinical, and Therapeutic Aspects

Muleiro Alvarez M, Cano-Herrera G, Osorio Martínez MF, Vega Gonzales-Portillo J, Monroy GR, Murguiondo Pérez R, Torres-Ríos JA, van Tienhoven XA, Garibaldi Bernot EM, Esparza Salazar F, Ibarra A.

Int J Mol Sci. 2024 Jun 29;25(13):7183. doi: 10.3390/ijms25137183.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias